Meeting Early Phase Study Challenges – a Data Management Perspective
First-in-Human studies are a discovery point, which can decide the fate of a compound as well as lay the groundwork for subsequent phases of a...
admin.veranex : Mar 24, 2025 10:22:50 PM
Jordan Hinahara and Thomas Goss, members of our Commercial Strategy and Market Access team, contributed to the budget impact model. The objective was to evaluate the economic impact of dasiglucagon compared with available glucagon treatments for SHE management, considering direct cost of treatment and health care resource utilization.
First-in-Human studies are a discovery point, which can decide the fate of a compound as well as lay the groundwork for subsequent phases of a...
Software is gaining relevancy in a broad range of medical devices, as it either enables the control or influence of their operation, or because...
5 min read
CT Image of Pulmonary Veins Atrial fibrillation remains a leading cause of death and disability and the most common type of arrhythmia....